China · Delayed Price · Currency is CNY Cofoe Medical Technology Statistics
Total Valuation
SHE:301087 has a market cap or net worth of CNY 9.62 billion. The enterprise value is 8.00 billion.
| Market Cap | 9.62B |
| Enterprise Value | 8.00B |
Important Dates
The next estimated earnings date is Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
SHE:301087 has 232.02 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 205.02M |
| Shares Outstanding | 232.02M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | +1.46% |
| Owned by Insiders (%) | 10.03% |
| Owned by Institutions (%) | 15.80% |
| Float | 110.16M |
Valuation Ratios
The trailing PE ratio is 23.34 and the forward PE ratio is 20.77. SHE:301087's PEG ratio is 1.07.
| PE Ratio | 23.34 |
| Forward PE | 20.77 |
| PS Ratio | 2.63 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | 17.63 |
| P/OCF Ratio | 13.97 |
| PEG Ratio | 1.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.86, with an EV/FCF ratio of 14.67.
| EV / Earnings | 20.67 |
| EV / Sales | 2.19 |
| EV / EBITDA | 14.86 |
| EV / EBIT | 22.63 |
| EV / FCF | 14.67 |
Financial Position
The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.21.
| Current Ratio | 2.07 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.90 |
| Debt / FCF | 1.87 |
| Interest Coverage | 21.98 |
Financial Efficiency
Return on equity (ROE) is 7.98% and return on invested capital (ROIC) is 9.57%.
| Return on Equity (ROE) | 7.98% |
| Return on Assets (ROA) | 3.32% |
| Return on Invested Capital (ROIC) | 9.57% |
| Return on Capital Employed (ROCE) | 7.21% |
| Weighted Average Cost of Capital (WACC) | 7.24% |
| Revenue Per Employee | 720,739 |
| Profits Per Employee | 76,210 |
| Employee Count | 5,081 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.62 |
Taxes
In the past 12 months, SHE:301087 has paid 59.29 million in taxes.
| Income Tax | 59.29M |
| Effective Tax Rate | 13.31% |
Stock Price Statistics
The stock price has increased by +35.66% in the last 52 weeks. The beta is 0.66, so SHE:301087's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +35.66% |
| 50-Day Moving Average | 49.59 |
| 200-Day Moving Average | 48.46 |
| Relative Strength Index (RSI) | 35.28 |
| Average Volume (20 Days) | 1,943,167 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301087 had revenue of CNY 3.66 billion and earned 387.23 million in profits. Earnings per share was 1.88.
| Revenue | 3.66B |
| Gross Profit | 1.94B |
| Operating Income | 353.75M |
| Pretax Income | 445.45M |
| Net Income | 387.23M |
| EBITDA | 471.04M |
| EBIT | 353.75M |
| Earnings Per Share (EPS) | 1.88 |
Balance Sheet
The company has 2.67 billion in cash and 1.02 billion in debt, with a net cash position of 1.65 billion or 7.11 per share.
| Cash & Cash Equivalents | 2.67B |
| Total Debt | 1.02B |
| Net Cash | 1.65B |
| Net Cash Per Share | 7.11 |
| Equity (Book Value) | 4.77B |
| Book Value Per Share | 23.08 |
| Working Capital | 2.15B |
Cash Flow
In the last 12 months, operating cash flow was 688.23 million and capital expenditures -142.72 million, giving a free cash flow of 545.51 million.
| Operating Cash Flow | 688.23M |
| Capital Expenditures | -142.72M |
| Depreciation & Amortization | 117.29M |
| Net Borrowing | 147.20M |
| Free Cash Flow | 545.51M |
| FCF Per Share | 2.35 |
Margins
Gross margin is 53.03%, with operating and profit margins of 9.66% and 10.57%.
| Gross Margin | 53.03% |
| Operating Margin | 9.66% |
| Pretax Margin | 12.16% |
| Profit Margin | 10.57% |
| EBITDA Margin | 12.86% |
| EBIT Margin | 9.66% |
| FCF Margin | 14.90% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 3.96%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 3.96% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 95.85% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 4.11% |
| Earnings Yield | 4.03% |
| FCF Yield | 5.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHE:301087 is 61.92, which is 41.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 61.92 |
| Price Target Difference | 41.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 19.48% |
| EPS Growth Forecast (3Y) | 29.51% |
Stock Splits
The last stock split was on May 20, 2022. It was a forward split with a ratio of 1.3000013.
| Last Split Date | May 20, 2022 |
| Split Type | Forward |
| Split Ratio | 1.3000013 |
Scores
SHE:301087 has an Altman Z-Score of 3.63 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.63 |
| Piotroski F-Score | 6 |